Perrigo Company plc (0Y5E.L)

USD 26.0

(-2.11%)

Total Liabilities Summary of Perrigo Company plc

  • Perrigo Company plc's latest annual total liabilities in 2023 was 6.04 Billion USD , down -2.17% from previous year.
  • Perrigo Company plc's latest quarterly total liabilities in 2024 Q2 was 5.85 Billion USD , down -1.7% from previous quarter.
  • Perrigo Company plc reported annual total liabilities of 6.17 Billion USD in 2022, up 17.09% from previous year.
  • Perrigo Company plc reported annual total liabilities of 5.27 Billion USD in 2021, down -9.59% from previous year.
  • Perrigo Company plc reported quarterly total liabilities of 5.85 Billion USD for 2024 Q2, down -1.7% from previous quarter.
  • Perrigo Company plc reported quarterly total liabilities of 6.12 Billion USD for 2023 Q1, down -0.88% from previous quarter.

Annual Total Liabilities Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Total Liabilities of Perrigo Company plc (2023 - 1992)

Year Total Liabilities Total Liabilities Growth
2023 6.04 Billion USD -2.17%
2022 6.17 Billion USD 17.09%
2021 5.27 Billion USD -9.59%
2020 5.83 Billion USD 6.11%
2019 5.49 Billion USD 3.42%
2018 5.31 Billion USD -2.62%
2017 5.45 Billion USD -31.02%
2016 7.91 Billion USD -12.64%
2015 9.05 Billion USD 74.64%
2014 5.18 Billion USD 71.84%
2013 3.01 Billion USD 39.0%
2012 2.17 Billion USD 30.95%
2011 1.65 Billion USD -17.26%
2010 2 Billion USD 24.14%
2009 1.61 Billion USD -1.64%
2008 1.64 Billion USD 40.21%
2007 1.17 Billion USD 5.48%
2006 1.1 Billion USD -0.38%
2005 1.11 Billion USD 399.92%
2004 222.86 Million USD 13.97%
2003 195.54 Million USD 10.08%
2002 177.64 Million USD -6.52%
2001 190.03 Million USD 42.48%
2000 133.38 Million USD -52.85%
1999 282.9 Million USD 12.98%
1998 250.4 Million USD 75.72%
1997 142.5 Million USD -15.28%
1996 168.2 Million USD -21.8%
1995 215.1 Million USD 19.83%
1994 179.5 Million USD 0.45%
1993 178.7 Million USD 34.16%
1992 133.2 Million USD 0.0%

Peer Total Liabilities Comparison of Perrigo Company plc

Name Total Liabilities Total Liabilities Difference
Editas Medicine, Inc. 150.05 Million USD -3925.964%
Dynavax Technologies Corporation 375.02 Million USD -1510.884%
Supernus Pharmaceuticals, Inc. 487.46 Million USD -1139.32%
Illumina, Inc. 4.36 Billion USD -38.369%
Thermo Fisher Scientific Inc. 51.88 Billion USD 88.356%
Iovance Biotherapeutics, Inc. 195.73 Million USD -2986.371%
Walgreens Boots Alliance, Inc. 68.85 Billion USD 91.226%
IQVIA Holdings Inc. 20.56 Billion USD 70.63%
Heron Therapeutics, Inc. 256.47 Million USD -2255.437%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 14.998%
Unity Biotechnology, Inc. 37.29 Million USD -16099.721%
Waters Corporation 3.47 Billion USD -73.772%
Biogen Inc. 12.04 Billion USD 49.846%
Sangamo Therapeutics, Inc. 82.43 Million USD -7228.618%
Evolus, Inc. 209.68 Million USD -2781.056%
Adicet Bio, Inc. 37.12 Million USD -16174.784%
Cara Therapeutics, Inc. 68.75 Million USD -8686.05%
bluebird bio, Inc. 424.62 Million USD -1322.718%
Esperion Therapeutics, Inc. 660.79 Million USD -814.239%
FibroGen, Inc. 585.72 Million USD -931.4%
Agilent Technologies, Inc. 4.91 Billion USD -22.839%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD -17073.665%
Homology Medicines, Inc. 118.53 Million USD -4996.64%
Geron Corporation 146.12 Million USD -4034.212%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD -49.146%
Amicus Therapeutics, Inc. 617.7 Million USD -878.006%
Myriad Genetics, Inc. 312.9 Million USD -1830.713%
Viking Therapeutics, Inc. 20.07 Million USD -29999.148%
Intellia Therapeutics, Inc. 250.8 Million USD -2308.695%
Zoetis Inc. 9.29 Billion USD 35.006%
Abeona Therapeutics Inc. 49.17 Million USD -12184.854%
Mettler-Toledo International Inc. 3.5 Billion USD -72.335%
BioMarin Pharmaceutical Inc. 1.89 Billion USD -219.631%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD -17.309%
Kala Pharmaceuticals, Inc. 48.44 Million USD -12370.224%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD -132.052%
Atara Biotherapeutics, Inc. 264.73 Million USD -2181.98%
Verastem, Inc. 71.18 Million USD -8386.619%
Nektar Therapeutics 267.04 Million USD -2162.232%
Axsome Therapeutics, Inc. 397.25 Million USD -1420.721%
Aclaris Therapeutics, Inc. 40.22 Million USD -14918.147%
Sarepta Therapeutics, Inc. 2.4 Billion USD -151.168%
OPKO Health, Inc. 622.47 Million USD -870.507%
Exelixis, Inc. 678.44 Million USD -790.448%
Neurocrine Biosciences, Inc. 1.01 Billion USD -492.623%
Corcept Therapeutics Incorporated 114.81 Million USD -5161.819%
Anavex Life Sciences Corp. 12.53 Million USD -48098.5%
uniQure N.V. 624.01 Million USD -868.112%
Imunon, Inc. 8.53 Million USD -70719.433%
Blueprint Medicines Corporation 918.64 Million USD -557.624%
Insmed Incorporated 1.66 Billion USD -263.542%
Halozyme Therapeutics, Inc. 1.64 Billion USD -266.253%
Agios Pharmaceuticals, Inc. 126.09 Million USD -4690.839%
TG Therapeutics, Inc. 169.08 Million USD -3472.878%
Incyte Corporation 1.59 Billion USD -279.408%
Emergent BioSolutions Inc. 1.18 Billion USD -409.548%